Bihua Chen - Jul 15, 2021 Form 3/A - Amendment Insider Report for Erasca, Inc. (ERAS)

Signature
/s/ CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP, By: Cormorant Global Healthcare GP, LLC, its General Partner, By: Bihua Chen, Managing Member
Stock symbol
ERAS
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
7/16/2021, 05:59 PM
Date Of Original Report
Jul 15, 2021
Next filing
Jul 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ERAS Stock Options (right to buy) Jul 15, 2021 Common Stock 167K $5.81 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were unintentionally omitted from the Reporting Person's original Form 3.
F2 Stock option grant for 166,666 shares, 41,667 shares of which become exercisable on 3/16/2022 and 124,999 shares of which become exercisable thereafter in equal monthly installments through 3/16/2025.
F3 Stock options granted to Bihua Chen, in her capacity as a director of the Issuer.